Table 4.
ID | EC50 (μM) |
β5 IC50 (μM) | Permeability | Metabolic stability m/hLM Clint | Kinet. Solu. | Cytotox. | cLogP | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
3D7 | Pf20S | c-20S | i-20S | PAMPA | Ratio /MDR1 | ||||||
23 | 0.21 | 3.2 | >100 | >100 | 186 | 5.5/37 | >768/471 | 4.2 | 106 | 6.0 | |
24 | >2.8 | >100 | >100 | >100 | 283 | 6.3/23 | >768/>768 | 4 | 100 | 6.0 | |
25 | 0.25 | 3.0 | >100 | >100 | 339 | 11/16 | >768/>768 | <0.85 | 100 | 6.3 |
PAMPA unit: nm/sec at pH7.4; MDR unit: ratio (B→A/A→B); A→B, nm/sec; Metabolic stability Clint unit: μL/min/mg; Kinet. Solu.: Kinetic solubility at pH6.8 (μg/mL); Cytotox.: cytotoxicity, % viability of HepG2 cells at 30 μM. “-”: not tested.